Kringle Pharma, Inc.

2026/08/21 Updated
Market Cap: $22.0M (¥3.5B)
Stock Price: $2.73 (¥434)
Exchange Rate: 1 USD = ¥158.98

Submission of the Clinical Trial Plan for a Phase III Additional Study of HGF (Hepatocyte Growth Factor) in the Acute Phase of Spinal Cord Injury

Importance:
Page Updated: June 19, 2026
IR Disclosure Date: June 19, 2026
その他

G-クリングル

Company overview · Stock price · Financial data · All IR

View company page →